Characterization of the Aldolase B Intronic Enhancer

Claudine Grégori, Arlette Porteu, Soledad López, Axel Kahn, Anne-Lise Pichard

Journal of Biological Chemistry · 1998 · 47 citations · 43 references

DOIFull text

Open access

Concepts

Abstract

The aldolase B gene is transcribed at a high level in the liver, kidney, and small intestine. This high level of gene expression results from cooperation between a weak but liver-specific promoter and an intronic activator. A deletional study of this activator present in the first intron allowed us to ascribe the maximal enhancer function to a 400-base pair (bp) fragment (+1916 to + 2329). This enhancer is highly liver-specific and enhances the activity of heterologous minimal promoters in a position and distance-independent fashion in transiently transfected Hep G2 hepatoma cells. The aldolase B enhancer is composed of two domains, a 200-bp module (Ba) inactive by itself but which synergizes with another 200-bp module (Bb) that alone retains 25% of the total enhancer activity. The Bb sequence is 76% homologous between human and rat genes and contains several binding sites for liver-enriched nuclear factors. By electrophoretic mobility shift assays, we demonstrated that elements 5 and 7 bind hepatic nuclear factor 1 (HNF1), whereas element 2 binds hepatic nuclear factor 4 (HNF4). A functional analysis of the enhancer whose elements have been mutated demonstrated that mutation of any of the HNF1 sites totally suppressed enhancer activity, whereas mutation of the HNF4-binding site reduced it by 80%. The aldolase B gene is transcribed at a high level in the liver, kidney, and small intestine. This high level of gene expression results from cooperation between a weak but liver-specific promoter and an intronic activator. A deletional study of this activator present in the first intron allowed us to ascribe the maximal enhancer function to a 400-base pair (bp) fragment (+1916 to + 2329). This enhancer is highly liver-specific and enhances the activity of heterologous minimal promoters in a position and distance-independent fashion in transiently transfected Hep G2 hepatoma cells. The aldolase B enhancer is composed of two domains, a 200-bp module (Ba) inactive by itself but which synergizes with another 200-bp module (Bb) that alone retains 25% of the total enhancer activity. The Bb sequence is 76% homologous between human and rat genes and contains several binding sites for liver-enriched nuclear factors. By electrophoretic mobility shift assays, we demonstrated that elements 5 and 7 bind hepatic nuclear factor 1 (HNF1), whereas element 2 binds hepatic nuclear factor 4 (HNF4). A functional analysis of the enhancer whose elements have been mutated demonstrated that mutation of any of the HNF1 sites totally suppressed enhancer activity, whereas mutation of the HNF4-binding site reduced it by 80%. base pair(s) kilobase pair(s) chloramphenicol acetyltransferase thymidine kinase hepatic nuclear factor chicken ovalbumin upstream promoter-transcription factor CAAT/enhancer binding protein L-type pyruvate kinase. Aldolase B, one of the three known aldolase isoenzymes, is the only expressed isoform in highly differentiated hepatocytes (1Schapira F. Hatzfeld A. Weber A. Markert C.L. Isozymes. 3. Academic Press, New York1975: 987-1003Crossref Google Scholar) and is also found in kidney and small adult intestine where it is associated with aldolases A or C (2Guder W.G. Ross B.D. Kidney Int. 1984; 26: 101-111Abstract Full Text PDF PubMed Scopus (396) Google Scholar). Aldolase B catalyzes the reversible cleavage of fructose 1-phosphate into dihydroxyacetone phosphate and glyceraldehyde; therefore, it is involved in both glycolytic and gluconeogenic pathways. In human, hereditary fructose intolerance is a potentially fatal autosomal recessive disease resulting from aldolase B deficiency. In addition aldolase B gene transcription is regulated by hormones and diet; it is partially repressed by glucagon and cyclic AMP and stimulated 4-fold by glucose and insulin (3Munnich A. Besmond C. Darguy S. Reach G. Vaulont S. Dreyfus J.C. Kahn A. J. Clin. Invest. 1985; 75: 1045-1052Crossref PubMed Scopus (39) Google Scholar). The aldolase B gene proximal promoter was shown to be liver cell-specific as judged from transient transfection experiments in the hepatoma cell line Hep G2 and in hepatocytes in primary culture (4Grégori C. Ginot F. Decaux J.F. Weber A. Berbar T. Kahn A. Pichard A.L. Biochem. Biophys. Res. Commun. 1991; 176: 722-729Crossref PubMed Scopus (21) Google Scholar). However the promoter activity of the −192-bp1 5′-flanking fragment was always very low in these cells. Recently we explained this result by a dominant restriction of the transcriptional activity due to binding of the hepatic nuclear factor 3 (HNF3) to the PAB element of the promoter (5Grégori C. Kahn A. Pichard A.L. Nucleic Acids Res. 1994; 22: 1242-1246Crossref PubMed Scopus (33) Google Scholar). This PAB element binds in a mutually exclusive fashion either hepatic nuclear factor 1 (HNF1), which stimulates promoter activity, or HNF3 that, on the contrary, restrained the aldolase B promoter activity (6Grégori C. Kahn A. Pichard A.L. Nucleic Acids Res. 1993; 21: 897-903Crossref PubMed Scopus (63) Google Scholar). In transgenic mice transgenes directed by the −232-bp proximal promoter fragment were totally silent. The addition of 1.8 kb of sequences located in the first intron of the aldolase B gene (+685 to +2514) led to a 50-fold stimulation of the promoter activity ex vivo in Hep G2 cells and allowed for a correct, tissue-specific expression in transgenic mice (7Sabourin J.-C. Kern A.-S. Gregori C. Porteu A. Cywiner C. Chatelet F.-P. Kahn A. Pichard A.-L. J. Biol. Chem. 1996; 271: 3469-3473Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar). The purpose of this work was to delineate the minimal intronic fragment responsible for the enhancer activity and to characterize DNA elements and cognate trans-acting factors involved in both activity and tissue specificity of this enhancer. Among various DNA elements detected in a 400-bp fragment endowed with a liver cell-specific enhancer activity, two HNF1-binding sites were shown to be indispensable for this activity. In addition, a conserved HNF4-binding site also behaved as a positive cis-acting element of the enhancer. For generation of the internal deletion, we started with the −232 A100B/CAT construct previously described (7Sabourin J.-C. Kern A.-S. Gregori C. Porteu A. Cywiner C. Chatelet F.-P. Kahn A. Pichard A.-L. J. Biol. Chem. 1996; 271: 3469-3473Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar). The −232A100B1200/CAT and −232A100B600/CAT plasmids were obtained by excision of a fragment between sites StuI (located within the B fragment) and KpnI or BamHI (located within the plasmid linkers). The −232A100Ba/CAT, −232A100Bb/CAT, −232A100Bc/CAT, and −232A100Ba+b/CAT plasmids were obtained by cloning in both orientations, into the SmaI site of the −232A100/CAT plasmid (7Sabourin J.-C. Kern A.-S. Gregori C. Porteu A. Cywiner C. Chatelet F.-P. Kahn A. Pichard A.-L. J. Biol. Chem. 1996; 271: 3469-3473Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar), the fragment of interest generated by polymerase chain reaction. The a+b polymerase chain reaction fragment was also subcloned in the AflIII site (located upstream from the promoter) or in the ClaI site (located downstream of the CAT gene) of the previously described pECAT vector (4Grégori C. Ginot F. Decaux J.F. Weber A. Berbar T. Kahn A. Pichard A.L. Biochem. Biophys. Res. Commun. 1991; 176: 722-729Crossref PubMed Scopus (21) Google Scholar). Then the various promoter fragments −232 A100 (7Sabourin J.-C. Kern A.-S. Gregori C. Porteu A. Cywiner C. Chatelet F.-P. Kahn A. Pichard A.-L. J. Biol. Chem. 1996; 271: 3469-3473Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar), −194 to + 14 (4Grégori C. Ginot F. Decaux J.F. Weber A. Berbar T. Kahn A. Pichard A.L. Biochem. Biophys. Res. Commun. 1991; 176: 722-729Crossref PubMed Scopus (21) Google Scholar) of the aldolase B gene, or −183 to + 11 of the pyruvate kinase gene (8Cognet M. Bergot M.O. Kahn A. J. Biol. Chem. 1991; 266: 7368-7375Abstract Full Text PDF PubMed Google Scholar), or −105 to +51 of the herpes simplex thymidine kinase (9Luckow B. Schütz G. Nucleic Acids Res. 1987; 15: 5490Crossref PubMed Scopus (1401) Google Scholar) gene were excised and subcloned in one or both of these two plasmids. Plasmids with block mutations in elements 5 and 7 or deletions in elements 2 and 4 were constructed by inserting the mutated fragments, obtained by a two-step polymerase chain reaction procedure (5Grégori C. Kahn A. Pichard A.L. Nucleic Acids Res. 1994; 22: 1242-1246Crossref PubMed Scopus (33) Google Scholar, 10Zaret K.S. Liu J.K. DiPersio M.C. Proc. Natl. Acad. Sci. U. S. A. 1990; 87: 5469-5473Crossref PubMed Scopus (69) Google Scholar), in the SmaI site of the −232A100 CAT plasmid. Sequence details on the block mutations are given in Fig. 4. All constructs were checked by DNA sequencing. The primer sequences used are available upon request. Hep G2 cells were grown in Dulbecco's modified medium in the presence of 10% (v/v) fetal calf serum, 1 μml-triiodothyronin, 1 μm dexamethasone, 10 nm insulin, at 37 °C in 5% (v/v) CO2. Mouse 3T6 cells were grown under the same conditions without hormones. Transfection were carried out by the calcium phosphate method (11Graham F.L. Van der Eb A.J. Virology. 1973; 52: 456-467Crossref PubMed Scopus (6499) Google Scholar), in conditions previously described (5Grégori C. Kahn A. Pichard A.L. Nucleic Acids Res. 1994; 22: 1242-1246Crossref PubMed Scopus (33) Google Scholar). In of the CAT plasmids and 2 of the plasmid were The plasmid was used to in transfection acetyltransferase Biol. PubMed Scopus Google Scholar) and M. S. Biol. 1987; PubMed Scopus Google Scholar) were as described (5Grégori C. Kahn A. Pichard A.L. Nucleic Acids Res. 1994; 22: 1242-1246Crossref PubMed Scopus (33) Google Scholar). from adult rat liver and were to M. U. Full Text PDF PubMed Scopus Google Scholar). The used as or were as element element element element rat S. M. Kahn A. M. J. Biol. PubMed Scopus Google Scholar), rat S. M. M. 1987; Full Text PDF PubMed Scopus Google Scholar), J. Biol. PubMed Scopus Google Scholar), rat S. M. Kahn A. M. J. Biol. PubMed Scopus Google Scholar), rat Biol. PubMed Scopus Google Scholar), human A. J. PubMed Scopus Google Scholar), Nucleic Acids Res. 26: PubMed Scopus Google Scholar), rat F. A. S. M. M. Biol. 1990; Google Scholar), Proc. Natl. Acad. U. S. A. 1991; PubMed Scopus Google Scholar), and shift in were as described M. S. M. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar) in the presence of as a as a analysis was by the reaction with or from F. and M. at for The DNA constructs were with restriction ClaI in in the and in in the plasmid The fragments of interest were by and by and into to and PubMed Scopus Google Scholar). The was for the presence of the by In we a B (+685 to +2514) in the first intron of the aldolase B gene that was for expression in the liver of transgenic mice (7Sabourin J.-C. Kern A.-S. Gregori C. Porteu A. Cywiner C. Chatelet F.-P. Kahn A. Pichard A.-L. J. Biol. Chem. 1996; 271: 3469-3473Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar). In transient transfection experiments in hepatoma Hep G2 this B fragment stimulated 50-fold the activity of a proximal aldolase B promoter (4Grégori C. Ginot F. Decaux J.F. Weber A. Berbar T. Kahn A. Pichard A.L. Biochem. Biophys. Res. Commun. 1991; 176: 722-729Crossref PubMed Scopus (21) Google Scholar). the sequences in this a of were and activity was in transient transfection experiments in Hep G2 cells of a restriction site in the B we first the of the upstream (+685 to and of the downstream (+1916 to +2514) of the B The expression of the construct of the B element in the downstream led to a stimulation of the activity. This to be the B due to position with to the minimal of these in three DNA fragments of fragments and that fragments and alone were totally whereas the Bb fragment to 25% of the with the of the fragments B the with the fragment results that the 400-bp from to is to the enhancer activity of the intronic B element of the aldolase B This 400-bp enhancer be into downstream by of the enhancer activity, and upstream by inactive but with the downstream to a enhancer activity. in vivo the of results obtained ex we generated transgenic mice the constructs The the upstream was totally inactive in 7 In transgenes either the downstream or of this were in out of 10 and were expressed in the liver and kidney but in the and previously (7Sabourin J.-C. Kern A.-S. Gregori C. Porteu A. Cywiner C. Chatelet F.-P. Kahn A. Pichard A.-L. J. Biol. Chem. 1996; 271: 3469-3473Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar), expression is highly on a position the various of activity and total in two with In any these results in vivo the of the enhancer of the aldolase B gene from ex vivo of the aldolase transgenes in activity + + expression is expressed by CAT activity, in results to the of three the of the in a expression is expressed by CAT activity, in results to the of three the of the The was the fragment of an enhancer and it was liver this we the a+b fragment in both in intronic position or in a kb upstream from the promoter or 1 kb downstream of the CAT The activity of these constructs was by transient in Hep G2 and the results are in The was totally of the or of the fragment and of position with to the either upstream from the promoter or downstream of the CAT gene or in intronic in with enhancer J. S. Full Text PDF PubMed Scopus Google Scholar). the enhancer was on a construct of the aldolase B promoter from −194 to + 14 and the first and the of the intronic sequence both the level of was this results from a cooperation between the enhancer and intronic sequences located in the and of the first intron or from a in the level of expression to the presence of a functional in mice but in transient transfection experiments B. A.L. S. M. A.J. Res. 1991; PubMed Scopus Google of the + intronic enhancer fragment in transiently transfected + + + + CAT + CAT + CAT + with with or without the + fragment in were transfected into either Hep G2 hepatoma cells or 3T6 the CAT activity was and by the activity generated by the plasmid. The −232A100 CAT construct contains of the aldolase B promoter of the intronic element A Fig. The CAT construct contains of the aldolase B promoter without The −183 CAT construct is by the L-type pyruvate kinase The −105 CAT construct is by the thymidine kinase The position of the + enhancer fragment present in the first intron of the aldolase B gene is with to the promoter and to the CAT In an intronic position in −232A100 CAT this fragment was in both + and + The results are expressed as with to the experiments were the results are given as the are and in are the of in a with with or without the + fragment in were transfected into either Hep G2 hepatoma cells or 3T6 the CAT activity was and by the activity generated by the plasmid. The −232A100 CAT construct contains of the aldolase B promoter of the intronic element A Fig. The CAT construct contains of the aldolase B promoter without The −183 CAT construct is by the L-type pyruvate kinase The −105 CAT construct is by the thymidine kinase The position of the + enhancer fragment present in the first intron of the aldolase B gene is with to the promoter and to the CAT In an intronic position in −232A100 CAT this fragment was in both + and + The results are expressed as with to the experiments were the results are given as the are and in are the of The activity of the enhancer fragment was also on heterologous either the liver-specific proximal promoter of the L-type pyruvate kinase gene (8Cognet M. Bergot M.O. Kahn A. J. Biol. Chem. 1991; 266: 7368-7375Abstract Full Text PDF PubMed Google Scholar) or the promoter of the thymidine kinase gene (9Luckow B. Schütz G. Nucleic Acids Res. 1987; 15: 5490Crossref PubMed Scopus (1401) Google Scholar). The fragment the activity of these promoters by and is that stimulation of the L-type pyruvate kinase promoter by the aldolase B enhancer was to that by the previously (8Cognet M. Bergot M.O. Kahn A. J. Biol. Chem. 1991; 266: 7368-7375Abstract Full Text PDF PubMed Google Scholar). the enhancer activity of the a+b fragment was by itself to liver the constructs either the aldolase B or the L-type pyruvate kinase or the with or without the were transiently transfected in 3T6 cells that the aldolase B The enhancer was to on the liver-specific aldolase B pyruvate kinase promoters as to the results that the aldolase enhancer was A analysis of the a+b enhancer sequence the S. Biol. 1994; PubMed Google Scholar) was the analysis of the Bb to enhancer fragment binding sites for liver-enriched nuclear factors as and CAAT/enhancer binding protein and for the this Bb fragment alone also of the enhancer function and is 76% conserved between human and rat aldolase B we on these that elements of the Bb fragment with we first used in vivo The in vivo protein the fragment that it was to from this we used this with the of binding sites to that were used for shift Fig. of sequence analysis and in experiments and the elements whose binding activity was by shift found that elements 1 and 3 bind factors present in both liver and nuclear in elements and 7 have a binding activity in liver and elements and 7 bind previously liver-specific transcription we used of known binding specificity as in the to element 2 was only for by the whereas binding to elements 5 and 7 were highly for by the HNF1 and by and In addition, binding activity of element 2 was by whereas binding of elements 5 and 7 were both by and shift analysis of elements and of the enhancer fragment The used for nuclear factor binding as as the are described under and All experiments were by 50-fold of The in B, and the of the of the is The position of by cognate and of or shift with liver or nuclear B, shift with liver nuclear with various known binding and 1 of or in the we used 1 of shift with either or element or element 4. shift of element shift of element shift of element shift of element The binding activity of element 4 was to experiments with for either were and of totally for the binding to element 4. The element 4 binding activity was also to In element 4 as as element 2 were in to the site element 4 bind of the nuclear from and bind with a low element factors are to to M. J. C. J. Biol. Chem. Full Text PDF PubMed Google Scholar), which is expressed in the as as in the element whose sequence was of an HNF3 to bind this nuclear factor in experiments as judged from experiments with an results that the aldolase B enhancer is in binding sites for at two liver-specific transcription HNF1 and The of elements and 7 to the enhancer in Hep G2 cells was by transient transfection of constructs in which of these element were mutated or in The mutations were obtained as described under and and the fragments were into an intronic position of the −232 A100 CAT aldolase B by electrophoretic mobility shift that mutated element 5 bind HNF1 in this element as as of the HNF1-binding element the enhancer totally both HNF1-binding sites were we an activity of the the level for the promoter of element sequences binding in an in the enhancer activity. of element 4 a upon the enhancer activity as the construct with this mutation of the activity of the enhancer. results that the aldolase B enhancer activity is on binding of the liver-enriched nuclear factors HNF1 and to cognate DNA A of the aldolase B enhancer is the of both HNF1-binding sites to be have previously described the promoter of the aldolase B gene which is liver-specific but the presence of an intronic enhancer to be in transiently transfected hepatoma cells (4Grégori C. Ginot F. Decaux J.F. Weber A. Berbar T. Kahn A. Pichard A.L. Biochem. Biophys. Res. Commun. 1991; 176: 722-729Crossref PubMed Scopus (21) Google Scholar). In transgenic any transgenes of this enhancer were totally whereas transgenes this element were expressed in the liver, kidney, and small intestine (7Sabourin J.-C. Kern A.-S. Gregori C. Porteu A. Cywiner C. Chatelet F.-P. Kahn A. Pichard A.-L. J. Biol. Chem. 1996; 271: 3469-3473Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar). the intronic was previously to a fragment whose cis-acting elements and cognate transcription factors been we described the of this liver-specific nuclear with and tissue and the of elements binding liver-enriched transcription HNF1 and deletional allowed us to ascribe the enhancer to a 400-bp fragment from to with to the site of This 400-bp fragment be into two and the is totally inactive by itself but to with the activity by Bb fragment alone is 25% only of the activity generated by the 400-bp enhancer This 400-bp aldolase B enhancer the of a it is functional in both and in any either upstream or downstream from the promoter as as in intronic the aldolase B enhancer is to heterologous either liver or this stimulation only in liver-specific cells G2 and in that this enhancer is by itself as is the aldolase B This tissue specificity been in transgenic mice a directed by a promoter in the liver M. S. F. C. M. M. C. J. Biochem. 1996; PubMed Scopus Google Scholar) in of the 400-bp aldolase B this construct was expressed in the liver as as in the kidney and small intestine tissue aldolase B. the 400-bp intronic enhancer of the aldolase B gene to an in both level and tissue specificity of aldolase B gene the cis-acting elements and cognate transcription factors involved in these The nuclear factors that are responsible for the tissue-specific transcription in differentiated liver cells HNF1 G. S. G. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar), HNF3 J. Biol. PubMed Scopus Google Scholar), 1990; PubMed Scopus Google Scholar), Proc. Natl. Acad. Sci. U. S. A. 1996; PubMed Scopus Google Scholar), PubMed Scopus Google Scholar), and S. U. Full Text PDF PubMed Scopus Google Scholar). The experiments with the aldolase B enhancer were first carried out in the Hep G2 hepatoma cells in which the of and are to found in the differentiated liver but which and PubMed Scopus Google Scholar). In the enhancer sequence a for the presence of binding sites for the transcription factors was resulting in the in fragment Bb of sequences for factors and shift experiments demonstrated that elements 5 and 7 bind HNF1 nuclear whereas element 2 binds The sequence of element 4 binding of both HNF3 and factors. the in a shift with an element detected in the presence of liver but of nuclear were by an of by factors are known to be in the B. S. A.J. S. G. 1994; PubMed Google Scholar), that it is that the with element 4 to these factors. the binding activity of element 4 was for by HNF4-binding sites and by whereas the element 4 itself was to we that this element bind in liver as of the nuclear we the of of the element in the of the aldolase B enhancer by or of HNF1-binding sites 5 and were also mutation or of either HNF1-binding site the enhancer whereas of both sites to restriction of the aldolase B promoter transcriptional activity. The of both HNF1-binding sites in to the enhancer function in a hepatoma cell line is a of this enhancer. A of several liver-specific is the cooperation between two or liver-enriched nuclear factors J. Biol. PubMed Scopus Google Scholar, A. A. M. M. J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar, Biol. 15: PubMed Google Scholar, S. J. Biol. Chem. 1996; 271: Full Text Full Text PDF PubMed Scopus Google Scholar, G. F. Nucleic Acids Res. PubMed Scopus Google Scholar). The of the aldolase B enhancer activity upon HNF1-binding sites in with the that the aldolase B gene is in the liver of mice M. J. M. A. C. C. M. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar). transcriptional activity of the aldolase B gene in these mice be explained by the presence of a of in the liver of the both of these factors binding to the same and transcriptional Biol. 15: PubMed Google Scholar, J. T. M. S. J. 1991; PubMed Scopus Google Scholar). is that of and for the function of HNF1-binding sites is a mice are totally in expression of the gene whose enhancer located upstream from the contains two HNF1-binding sites S. T. M.C. Biol. 1996; PubMed Scopus Google Scholar). The gene also contains two HNF1-binding sites position and is in mice M. A. M. M.C. Biol. PubMed Google Scholar). it be that the of in of the gene is by at at in the In the kidney, by the of is in the liver, and the gene in it be that high of either or are to of the gene, whereas in the liver of mice be to activity of the aldolase B enhancer whose on factors. The HNF4-binding site also to be for the aldolase B gene enhancer activity results in an of transcriptional activity, which is with the by M. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar) that the aldolase B gene is in In of element 4 binding factors a of is that the of HNF1 and as indispensable factors for a enhancer function that these factors are to this In of with −105 construct and both and HNF1 expression for stimulation of the CAT is that transcription work with to from a binding with the proximal promoter This the binding of HNF1 and to the aldolase B enhancer in cells is to the gene, of the factors or In specificity and activity of the intronic aldolase B gene enhancer on binding sites for liver-specific HNF1 and factors. either of the two HNF1-binding sites is for the enhancer activity. the aldolase B gene proximal promoter binding sites for HNF1 PAB to M. Pichard A.L. Gregori C. Kahn A. Nucleic Acids Res. 1991; PubMed Scopus Google as for located from to A. and A.-L. a cooperation between these factors to the promoter and the enhancer to be the enhancer also very with the −105 elements for both liver-specific and the aldolase B enhancer to be a and highly tissue-specific enhancer for gene expression to the liver, proximal of the kidney, and of the small intestine. are very to for and to for

References

43